Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts
Amy J. Grizzle, PharmD;Maysaa H. Mahmood, MS;Yu Ko, MS;John E. Murphy, PharmD;Edward P. Armstrong, PharmD;Grant H. Skrepnek, PhD;William N. Jones, MS;Gregory P. Schepers, PharmD;W. Paul Nichol, MD;Antoun Houranieh, PhD;Donna C. Dare, PharmD;Christopher T. Hoey, PharmD;Daniel C. Malone, PhD October 1st 2007ArticleMANAGERIAL